NCT00201682View on ClinicalTrials.gov

Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2009

Conditions
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Interventions
DRUG

Etanercept

25 mg SQ twice weekly weeks 1-5

DRUG

Rituximab

(375 mg/m2) Using Stepped-Up Dosing Thrice Weekly, weeks 2-5

Trial Locations (1)

43210

Ohio State University Medical Center, Columbus

All Listed Sponsors
lead

John Byrd

OTHER

NCT00201682 - Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma | Biotech Hunter | Biotech Hunter